Multicenter clinical trials have clearly demonstrated the advantages of these stents in reducing major cardiovascular outcomes, particularly target vessel revascularization tvr, compared with bare metal stents 1. As shown in a metaanalysis by kastrati 8 and more recently in a meta analysis by stettler 9. Celleci peut etre realisee soit par angioplastie primaire soit par thrombolyse. Mar 20, 2015 comparison of the efficacy of drugeluting stents versus baremetal stents for the treatment of left main coronary artery disease xiaozeng wang, 1 kai xu, 1 yi li, 1 quanmin jing, 1 haiwei liu, 1 xin zhao, 1 geng wang, 1 bin wang, 1 yingyan ma, 1 shaoliang chen, 2 and yaling han 1. The high price of drug eluting stents relative to bare stents has been an obstacle to more widespread utilization of drug eluting stents. The full text of this article is available in pdf format. We sought to explore theimmediate outcome of titaniumnitrideoxidecoated bioactive stent, titan2, in realworld practice, and the incidence of major. Comparison of the efficacy of drugeluting stents versus bare. May 01, 2020 approximately 5% of patients referred for coronary stenting are on longterm oral anticoagulation. Les stents coronaires pour eviter linfarctus cardiologie. Cardiologie interventionnelle une domination des stents actifs p. The frequency of various clinical outcomes of bare metal stents and des differs between clinical trial data and observational studies. Novel p2y12 antagonists currently under investigation.
Coronary stents have evolved over time, from baremetal stents to drugeluting and now to bioactive stents. Cardiologie interventionnelle une domination des stents actifs. Evenements a 6 mois stents actifs risques taxus iv. Le succes des stents lapparition des stents a eu deux consequences majeures. Dr mohamed islem soualhi dr yacine bourahli 2016 2.
Novel p2y12 antagonists currently under investigation, including cangrelor and prasugrel are. Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. The saga of the duration of dual antiplatelet therapy after. Use of drugeluting stents in this patient group varies from 2 to 100% according to local practice.
Cardiologie interventionnelle une domination des stents. Although clinical trials have demonstrated similar mortality and mi rates for des and bare metal stents, observational realworld studies indicate a reduction in mortality in the des group 2125. Approximately 5% of patients referred for coronary stenting are on longterm oral anticoagulation. In one lesion, the restenotic segment could not be completely covered by the stent, and in another lesion, a bare metal stent was implanted distally to the quadsqp2 stent. Stents coronaires actifs et bitherapie antiagregante. Randomized clinical trials have not included des, despite their increased use. Le monde tres actif des stents actifs cardiologie pratique. Translation for stent in the free englishfrench dictionary and many other french translations.
Anesthesiologists managing patients with drugeluting stents des face the challenge of balancing the risks of bleedingvs perioperative stent thrombosis st. Aug 01, 2016 syndrome coronarien aigue 2016 slideshare 1. Utilisation des stents actifs dans les lesions complexes. Comparison of the efficacy of drugeluting stents versus baremetal stents for the treatment of left main coronary artery disease xiaozeng wang, 1 kai xu, 1 yi li, 1 quanmin jing, 1 haiwei liu, 1 xin zhao, 1 geng wang, 1 bin wang, 1 yingyan ma, 1 shaoliang chen, 2 and yaling han 1. References 1 gharbi m, belhani a, ben aleya a, aouidet a, nasraoui a, achour a, et al. Efficacy and safety of drugeluting stents in the real. Conflicting data exist on the risk of stent thrombosis with drugeluting stents des versus baremetal stents bms.
641 17 768 1289 99 1466 45 664 119 801 408 1323 850 1284 139 205 243 880 372 639 274 551 1420 1612 287 429 813 124 1065 1373 946 196 951 828 924 987 710